Abstract
Anxiety disorders constitute important, though for a long time, neglected comorbidities of epilepsy. They deserve attention, because they are frequent and negatively impact the quality of life of persons with epilepsy. This chapter covers aspects of the neurobiological and pathophysiological correlates of anxiety and anxiety disorders, classification and differential diagnosis of epilepsy-related anxiety, epidemiology, the relationship between anxiety and different forms of epilepsy, and the influence of epilepsy surgery on concomitant anxiety. The bidirectional relationship between epilepsy and anxiety deserves broad attention, as this extends to the different levels of this comorbidity from animal models (for instance, GAERS rats may show increased levels of anxiety when compared to healthy controls, already before the onset of epilepsy) to epidemiology (anxiety may be detected up to 3 years before epilepsy diagnosis). Treatment (drugs, psychotherapy, alternative treatments) is also covered. Selective serotonin-reuptake inhibitors and serotonin-noradrenalin reuptake inhibitors are established in the treatment of anxiety disorders. It would be of value in persons with epilepsy and a comorbid anxiety disorder to treat both conditions with a single drug, which leads to the issue of anxiolytic properties of antiepileptic drugs (AEDs). Strong evidence has been demonstrated for pregabalin in social phobia and generalized anxiety disorder, lamotrigine in posttraumatic stress disorder, and gabapentin in social anxiety. Anxiety may also be a side effect of AEDs. Case vignettes at the end of the chapter illustrate the issue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kanner AM. Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr. 2011;11(3):90–1.
Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164(10):1476–88.
Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. 2003;60(5):749–56.
Stahl SM. Brainstorms: symptoms and circuits, part 2: anxiety disorders. J Clin Psychiatry. 2003;64(12):1408–9.
Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med. 2004;10:685–92.
Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007;27(3):263–72.
Rocha L, Alonso-Vanegas M, Martinez-Juarez IE, Orozco-Suarez S, Escalante-Santiago D, Feria-Romero IA, et al. GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors. Front Cell Neurosci. 2014;8:442.
Mula M, Monaco F. Ictal and peri-ictal psychopathology. Behav Neurol. 2011;24(1):21–5.
Guimond A, Braun CM, Belanger E, Rouleau I. Ictal fear depends on the cerebral laterality of the epileptic activity. Epileptic Disord. 2008;10(2):101–12.
Oehl B, Schulze-Bonhage A, Lanz M, Brandt A, Altenmuller DM. Occipital lobe epilepsy with fear as leading ictal symptom. Epilepsy Behav. 2012;23(3):379–83.
Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110(4):207–20.
Chiesa V, Gardella E, Tassi L, Canger R, Lo Russo G, Piazzini A, et al. Age-related gender differences in reporting ictal fear: analysis of case histories and review of the literature. Epilepsia. 2007;48(12):2361–4.
Toth V, Fogarasi A, Karadi K, Kovacs N, Ebner A, Janszky J. Ictal affective symptoms in temporal lobe epilepsy are related to gender and age. Epilepsia. 2010;51(7):1126–32.
Feichtinger M, Pauli E, Schafer I, Eberhardt KW, Tomandl B, Huk J, et al. Ictal fear in temporal lobe epilepsy: surgical outcome and focal hippocampal changes revealed by proton magnetic resonance spectroscopy imaging. Arch Neurol. 2001;58(5):771–7.
Schoendienst M, Reuber M. Epilepsy and anxiety. In: Schachter S, Holmes G, Kasteleijn-Nolst Trenité D, editors. Behavioral aspects of epilepsy. New York: Demos; 2008. p. 219–26.
Goldstein LH, Mellers JD. Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures. J Neurol Neurosurg Psychiatry. 2006;77(5):616–21.
Bragatti JA, Torres CM, Londero RG, Assmann JB, Fontana V, Martin KC, et al. Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews. Epileptic Disord. 2010;12(4):283–91.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archiv Intern Med. 2006;166(10):1092–7.
Seo JG, Cho YW, Lee SJ, Lee JJ, Kim JE, Moon HJ, et al. Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study. Epilepsy Behav. 2014;35:59–63.
Harter C, Brandt C, Angenendt J. Agoraphobia with panic disorder or epilepsy? Differential diagnostic considerations in a case. Psychiatr Prax. 2000;27(5):252–4.
Kanner AM, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 2004;62(5):708–13.
Sperling MR, Schilling CA, Glosser D, Tracy JI, Asadi-Pooya AA. Self-perception of seizure precipitants and their relation to anxiety level, depression, and health locus of control in epilepsy. Seizure. 2008;17(4):302–7.
Haut SR, Hall CB, Borkowski T, Tennen H, Lipton RB. Clinical features of the pre-ictal state: mood changes and premonitory symptoms. Epilepsy Behav. 2012;23(4):415–21.
Privitera M, Walters M, Lee I, Polak E, Fleck A, Schwieterman D, et al. Characteristics of people with self-reported stress-precipitated seizures. Epilepsy Behav. 2014;41:74–7.
Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48(12):2336–44.
Rai D, Kerr MP, McManus S, Jordanova V, Lewis G, Brugha TS. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia. 2012;53(6):1095–103.
Robertson MM, Trimble MR, Townsend HR. Phenomenology of depression in epilepsy. Epilepsia. 1987;28(4):364–72.
Brandt C, Schoendienst M, Trentowska M, May TW, Pohlmann-Eden B, Tuschen-Caffier B, et al. Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey. Epilepsy Behav. 2010;17(2):259–63.
Illies D, Herzig C, Schröder K, Schöndienst M, Brandt C, Neuner F, et al. Psychische Störungen bei Patienten mit fokalen und generalisierten Epilepsien. In: Vögele C, editor. 30 Symposium Klinische Psychologie und Psychotherapie der DGPs Fachgruppe Klinische Psychologie und Psychotherapie; Luxemburg. Luxemburg: University of Luxemburg; 2012. p. 113–4.
Gandy M, Sharpe L, Perry KN, Miller L, Thayer Z, Boserio J, et al. Rates of DSM-IV mood, anxiety disorders, and suicidality in Australian adult epilepsy outpatients: a comparison of well-controlled versus refractory epilepsy. Epilepsy Behav. 2013;26(1):29–35.
Maroufi A, Khomand P, Ahmadiani S, Alizadeh NS, Gharibi F. Prevalence and quality of anxiety in patients with epilepsy. Epilepsy Behav. 2014;32:34–7.
Al-Khateeb JM, Al-Khateeb AJ. Research on psychosocial aspects of epilepsy in Arab countries: a review of literature. Epilepsy Behav. 2014;31:256–62.
Reilly C, Agnew R, Neville BG. Depression and anxiety in childhood epilepsy: a review. Seizure. 2011;20(8):589–97.
Jones JE, Blocher JB, Jackson DC, Sung C, Fujikawa M. Social anxiety and self-concept in children with epilepsy: a pilot intervention study. Seizure. 2014;23(9):780–5.
Spielberger CD, Gorssuch RL, Lushene PR, Vagg PR, Jacobs GA. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press; 1983.
Jacoby A, Snape D, Lane S, Baker GA. Self-reported anxiety and sleep problems in people with epilepsy and their association with quality of life. Epilepsy Behav. 2015;43:149–58.
Bjork MH, Veiby G, Reiter SC, Berle JO, Daltveit AK, Spigset O, et al. Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis. Epilepsia. 2015;56(1):28–39.
Mensah SA, Beavis JM, Thapar AK, Kerr MP. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav. 2007;11(1):118–24.
Kimiskidis VK, Triantafyllou NI, Kararizou E, Gatzonis SS, Fountoulakis KN, Siatouni A, et al. Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry. 2007;6:28.
Asadi-Pooya AA, Schilling CA, Glosser D, Tracy JI, Sperling MR. Health locus of control in patients with epilepsy and its relationship to anxiety, depression, and seizure control. Epilepsy Behav. 2007;11(3):347–50.
Endermann M, Zimmermann F. Factors associated with health-related quality of life, anxiety and depression among young adults with epilepsy and mild cognitive impairments in short-term residential care. Seizure. 2009;18(3):167–75.
McCagh J, Fisk JE, Baker GA. Epilepsy, psychosocial and cognitive functioning. Epilepsy Res. 2009;86(1):1–14.
Goldstein LH, Holland L, Soteriou H, Mellers JD. Illness representations, coping styles and mood in adults with epilepsy. Epilepsy Res. 2005;67(1–2):1–11.
Thompson PJ, Upton D. The impact of chronic epilepsy on the family. Seizure. 1992;1(1):43–8.
Gandy M, Sharpe L, Perry KN. Psychosocial predictors of depression and anxiety in patients with epilepsy: a systematic review. J Affect Disord. 2012;140(3):222–32.
Peterson CL, Walker C, Shears G. The social context of anxiety and depression: exploring the role of anxiety and depression in the lives of Australian adults with epilepsy. Epilepsy Behav. 2014;34:29–33.
Arida RM, Gomes da Silva S, de Almeida AA, Cavalheiro EA, Zavala-Tecuapetla C, Brand S, et al. Differential effects of exercise on brain opioid receptor binding and activation in rats. J Neurochem. 2015;132(2):206–17.
Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ. Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia. 2010;51(7):1152–8.
Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72(2):184–91.
Tang WK, Lu J, Ungvari GS, Wong KS, Kwan P. Anxiety symptoms in patients with frontal lobe epilepsy versus generalized epilepsy. Seizure. 2012;21(6):457–60.
Altshuler LL, Devinsky O, Post RM, Theodore W. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol. 1990;47(3):284–8.
Sperli F, Rentsch D, Despland PA, Foletti G, Jallon P, Picard F, et al. Psychiatric comorbidity in patients evaluated for chronic epilepsy: a differential role of the right hemisphere? Eur Neruol. 2009;61(6):350–7.
Swinkels WA, van Emde Boas W, Kuyk J, van Dyck R, Spinhoven P. Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE. Epilepsia. 2006;47(12):2092–103.
Kanner AM. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009;15(1):83–7.
Jones NC, Salzberg MR, Kumar G, Couper A, Morris MJ, O’Brien TJ. Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp Neurol. 2008;209(1):254–60.
Dailey JW, Mishra PK, Ko KH, Penny JE, Jobe PC. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci. 1992;50(4):319–26.
Loss CM, Cordova SD, de Oliveira DL. Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats. Brain Res. 2012;1474:110–7.
Duarte FS, Duzzioni M, Hoeller AA, Silva NM, Ern AL, Piermartiri TC, et al. Anxiogenic-like profile of Wistar adult rats based on the pilocarpine model: an animal model for trait anxiety? Psychopharmacology (Berl). 2013;227(2):209–19.
O’Loughlin EK, Pakan JM, McDermott KW, Yilmazer-Hanke D. Expression of neuropeptide Y1 receptors in the amygdala and hippocampus and anxiety-like behavior associated with Ammon’s horn sclerosis following intrahippocampal kainate injection in C57BL/6 J mice. Epilepsy Behav. 2014;37:175–83.
Kanner AM. Lennox-lombroso lecture, 2013: psychiatric comorbidities through the life of the seizure disorder: a complex relation with a not so complex solution. Epilepsy Curr. 2014;14(6):323–8.
Cleary RA, Baxendale SA, Thompson PJ, Foong J. Predicting and preventing psychopathology following temporal lobe epilepsy surgery. Epilepsy Behav. 2013;26(3):322–34.
Guarnieri R, Walz R, Hallak JE, Coimbra E, de Almeida E, Cescato MP, et al. Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery? Epilepsy Behav. 2009;14(3):529–34.
Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72(9):793–9.
Meldolesi GN, Di Gennaro G, Quarato PP, Esposito V, Grammaldo LG, Morosini P, et al. Changes in depression, anxiety, anger, and personality after resective surgery for drug-resistant temporal lobe epilepsy: a 2-year follow-up study. Epilepsy Res. 2007;77(1):22–30.
Devinsky O, Barr WB, Vickrey BG, Berg AT, Bazil CW, Pacia SV, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005;65(11):1744–9.
Hamid H, Blackmon K, Cong X, Dziura J, Atlas LY, Vickrey BG, et al. Mood, anxiety, and incomplete seizure control affect quality of life after epilepsy surgery. Neurology. 2014;82(10):887–94.
Kwan P, Yu E, Leung H, Leon T, Mychaskiw MA. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia. 2009;50(5):1059–66.
Stevanovic D, Jancic J, Lakic A. The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia. 2011;52(8):e75–8.
Gomez-Arias B, Crail-Melendez D, Lopez-Zapata R, Martinez-Juarez IE. Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs. Seizure. 2012;21(8):588–94.
Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol. 2007;6(8):693–8.
Brown FC, Westerveld M, Langfitt JT, Hamberger M, Hamid H, Shinnar S, et al. Influence of anxiety on memory performance in temporal lobe epilepsy. Epilepsy Behav. 2014;31:19–24.
Hamilton KT, Anderson CT, Dahodwala N, Lawler K, Hesdorffer D, French J, et al. Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depression. Seizure. 2014;23(3):196–200.
Piedad J, Rickards H, Besag FM, Cavanna AE. Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS Drugs. 2012;26(4):319–35.
Moseley BD, Cole D, Iwuora O, Strawn JR, Privitera M. The effects of lacosamide on depression and anxiety in patients with epilepsy. Epilepsy Res. 2015;110:115–8.
Mula M. Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia. 2013;54 Suppl 1:13–8.
Bandelow B, Lichte T, Rudolf S, Wiltink J, Beutel ME. The German guidelines for the treatment of anxiety disorders. Eur Arch Psychiatry Clin Neurosci. 2015;265(5):363–73.
Bandelow B, Boerner JR, Kasper S, Linden M, Wittchen HU, Moller HJ. The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int. 2013;110(17):300–9; quiz 310.
Brandt C, Schoendienst M, Trentowska M, Schrecke M, Fueratsch N, Witte-Boelt K, et al. Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders – results of an open-label, parallel group, investigator-initiated, proof-of-concept study. Epilepsy Behav. 2013;29(2):298–304.
Hagemann A, May TW, Nieder E, Witte-Bolt K, Pohlmann-Eden B, Elger CE, et al. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Res. 2013;104(1–2):140–50.
Mula M, Trimble MR, Yuen A, Liu RS, Sander JW. Psychiatric adverse events during levetiracetam therapy. Neurology. 2003;61(5):704–6.
Kanner AM. When did neurologists and psychiatrists stop talking to each other? Epilepsy Behav. 2003;4(6):597–601.
Kanner AM. Is it time to train neurologists in the management of mood and anxiety disorders? Epilepsy Behav. 2014;34:139–43.
Chen JJ, Caller TA, Mecchella JN, Thakur DS, Homa K, Finn CT, et al. Reducing severity of comorbid psychiatric symptoms in an epilepsy clinic using a colocation model: results of a pilot intervention. Epilepsy Behav. 2014;39:92–6.
Pfäfflin M, Fraser RT, Thorbecke R, Specht U, Wolf P (eds.) Comprehensive care for people with epilepsy. Eastleigh: John Libbey Eurotext; 2001.
Macrodimitris S, Wershler J, Hatfield M, Hamilton K, Backs-Dermott B, Mothersill K, et al. Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety. Epilepsy Behav. 2011;20(1):83–8.
Goossens L, Sunaert S, Peeters R, Griez EJ, Schruers KR. Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psychiatry. 2007;62(10):1119–25.
Baxendale S, O’Sullivan J, Heaney D. Bright light therapy for symptoms of anxiety and depression in focal epilepsy: randomised controlled trial. Br J Psychiatry. 2013;202(5):352–6.
Acknowledgments
I would like to thank Michael Frauenheim, MD, and Kirsten Labudda, PhD, my co-heads at the ward for behavior medicine and psychotherapy in epileptology at Bethel Epilepsy Centre, for their valuable contributions to the pathophysiology part of the chapter and to the case reports.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Brandt, C. (2016). Anxiety. In: Mula, M. (eds) Neuropsychiatric Symptoms of Epilepsy. Neuropsychiatric Symptoms of Neurological Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-22159-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-22159-5_4
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22158-8
Online ISBN: 978-3-319-22159-5
eBook Packages: MedicineMedicine (R0)